Catalyst Wire Dossier Catalyst Wire Dossier

NNG-DEPO (Stimus)

· Nanogen Pharmaceutical Biotechnology Joint Stock Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNG-DEPO (Stimus), covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis [Phase 1]

See pricing